Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.913424
Abstract: Background Allergic rhinoconjunctivitis (ARC) is an allergic disease that is characterized by conjunctival and nasal symptoms such as edema and congestion of conjunctiva, rhinorrhea, sneezing, and blocked nose. Seasonal ARC (SARC) is usually induced by… read more here.
Keywords: allergic rhinoconjunctivitis; preventative efficacy; efficacy omalizumab; treatment ... See more keywords